Disease · HP_0002015
Comparisons in its trials15
Comparisons Trial comparisons calculated in the trials shown here, most participants first. A comparison in one of these trials does not always compare a treatment for the disease, so read the two groups.
1 to 15 of 15
Download this page as JSON| Comparison | Group 1, with the outcome | Group 2, with the outcome | Participants | Trial | Source |
|---|---|---|---|---|---|
| Oral Budesonide Suspension (OBS) vs Placebo: deaths from any cause | 0 of 213 | 0 of 105 | 318 | NCT02605837 | Trial comparisons |
| Oral Budesonide Suspension (OBS) vs Placebo: Number of Participants With Treatment-Emergent Adverse Events (AE) | 130 of 213 | 64 of 105 | 318 | NCT02605837 | Trial comparisons |
| Oral Budesonide Suspension (OBS) vs Placebo: serious adverse events | 2 of 213 | 1 of 105 | 318 | NCT02605837 | Trial comparisons |
| Overall Period Octagam vs First Period Placebo: deaths from any cause | 0 of 95 | 0 of 48 | 143 | NCT02728752 | Trial comparisons |
| Overall Period Octagam vs First Period Placebo: serious adverse events | 14 of 95 | 2 of 48 | 143 | NCT02728752 | Trial comparisons |
| Octagam10% vs Placebo: Measure the Number of Patients Who Had an Increase of ≥20 Points on the Total Improvement Score (TIS) | 37 of 47 | 21 of 48 | 95 | NCT02728752 | Trial comparisons |
| Speech Language Therapy Alone vs Speech Language Therapy and Acid Suppression Therapy: Number of Participants With the Need for Supraglottoplasty Surgery (Escalation of Treatment) up to 1 Year | 2 of 34 | 1 of 31 | 65 | NCT04614974 | Trial comparisons |
| Speech Language Therapy Alone vs Speech Language Therapy and Acid Suppression Therapy: deaths from any cause | 0 of 34 | 0 of 31 | 65 | NCT04614974 | Trial comparisons |
Speech Language Therapy Alone vs Speech Language Therapy and Acid Suppression Therapy: Number of Participants With the Need for a Different Acid Suppression Therapy Medication (Other Than Famotidine) From the Day After the Consult up to the 3 Month Follow up Appointment | 0 of 34 | 2 of 31 | 65 | NCT04614974 | Trial comparisons |
| Speech Language Therapy Alone vs Speech Language Therapy and Acid Suppression Therapy: serious adverse events | 3 of 34 | 3 of 31 | 65 | NCT04614974 | Trial comparisons |
| Treatment 1; Dexamethasone vs Treatment 0; Saline Placebo: deaths from any cause | 0 of 33 | 0 of 31 | 64 | NCT02416934 | Trial comparisons |
| Treatment 1; Dexamethasone vs Treatment 0; Saline Placebo: serious adverse events | 0 of 33 | 0 of 31 | 64 | NCT02416934 | Trial comparisons |
| Group A Receives Routine Care and Esophageal Dilatation vs Group B Receives SOC Only: serious adverse events | 0 of 17 | 0 of 14 | 31 | NCT00880906 | Trial comparisons |
| Normal Subjects vs Stroke Subjects: serious adverse events | 0 of 21 | 2 of 7 | 28 | NCT01085903 | Trial comparisons |
| Dexamethasone vs Saline: serious adverse events | 0 of 1 | 0 of 3 | 4 | NCT02266797 | Trial comparisons |
diseases-2026-09-18-0.1.0
Sources 6
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- NLM's MeSHNLM's terms
- Open TargetsCC0 1.0
- PubMedNLM's terms
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- NLM's MeSHNLM's
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/diseases/v1/HP_0002015/comparisons